References

1. Canadian Agency for Drugs and Technologies in Health. Optimal Therapy Recommendations for the Prescribing and Use of Blood Glucose Test Strips. Ottawa: Canadian Agency for Drugs and Technologies in Health, 2010.

2. Bergenstal RM, Gavin JR^3rd. The role of self-monitoring of blood glucose in the care of people with diabetes: report of a global consensus conference. The American Journal of Medicine 2005; 118(Suppl 9A): 1S-6S.

3. Canadian Agency for Drugs and Technologies in Health. Systematic Review of Use of Blood Glucose Test Strips for the Management of Diabetes Mellitus. Ottawa: Canadian Agency for Drugs and Technologies in Health, 2010.

4. Martin S, Schneider B, Heinemann L, et al. Self-monitoring of blood glucose in type 2 diabetes and long-term outcome: an epidemiological cohort study. Diabetologia 2006; 49(2): 271-8.

5. Guerci B, Drouin P, Grange V, et al. Self-monitoring of blood glucose significantly improves metabolic control in patients with type 2 diabetes mellitus: the Auto-Surveillance Intervention Active (ASIA) study. Diabetes and Metabolism 2003; 29(6): 587-94.

6. Davidson MB, Castellanos M, Kain D, Duran P. The effect of self monitoring of blood glucose concentrations on glycated hemoglobin levels in diabetic patients not taking insulin: a blinded, randomized trial. The American Journal of Medicine 2005; 118(4): 422-5.

7. Welschen LM, Bloemendal E, Nijpels G, et al. Self-monitoring of blood glucose in patients with type 2 diabetes mellitus who are not using insulin. Cochrane Database of Systematic Reviews 2005(2): CD005060.

8. Malanda UL, Welschen LM, Riphagen II, et al. Self-monitoring of blood glucose in patients with type 2 diabetes mellitus who are not using insulin. Cochrane Database of Systematic Reviews 2012; 1: CD005060.

9. St John A, Davis WA, Price CP, Davis TM. The value of self-monitoring of blood glucose: a review of recent evidence. Journal of Diabetes and its Complications 2010; 24(2): 129-41.

10. Bodmer M, Meier C, Krahenbuhl S, et al. Metformin, sulfonylureas, or other antidiabetes drugs and the risk of lactic acidosis or hypoglycemia: a nested case-control analysis. Diabetes Care 2008; 31(11): 2086-91.

11. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Canadian Diabetes Association 2008 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada. Toronto: Canadian Diabetes Association, 2008.

12. Johnson JA, Pohar SL, Secnik K, et al. Utilization of diabetes medication and cost of testing supplies in Saskatchewan, 2001. BMC Health Services Research 2006; 6: 159.

13. Gomes T, Juurlink DN, Shah BR, et al. Blood glucose test strips: options to reduce usage. Canadian Medical Association Journal 2010; 182(1): 35-8.

14. Self-monitoring of blood glucose in type 2 diabetes: an inter-country comparison. Diabetes Research and Clinical Practice 2008; 82(3): e15-8.

15. Karter AJ, Parker MM, Moffet HH, et al. Longitudinal study of new and prevalent use of self-monitoring of blood glucose. Diabetes Care 2006; 29(8): 1757-63.

16. Morgan CL, Griffin A, Chamberlain GH, et al. A longitudinal study into the new and long-term use of self-monitoring blood glucose strips in the UK. Diabetes Therapy 2010; 1(1): 1-9.

17. Nwasuruba C, Khan M, Egede LE. Racial/ethnic differences in multiple self-care behaviors in adults with diabetes. Journal of General Internal Medicine 2007; 22(1): 115-20.

18. Canadian Institute of Health Information. Diabetes Care Gaps and Disparities in Canada. Ottawa: Canadian Institute of Health Information, 2009. Available at:  http://secure.cihi.ca/free_products/Diabetes_care_gaps_disparities_aib_e.pdf. Accessed May 11, 2012.

19. Hjelm K, Nyberg P, Apelqvist J. Self-monitoring of blood glucose; frequency, determinants and self-adjustment of treatment in an adult Swedish diabetic population: utilisation and determinants of SMBG. Practical Diabetes International 2011; 18(5): 157-63.

20. Statistics Canada. Survey on Living with Chronic Diseases in Canada (SLCDC). Ottawa: Statistics Canada, 2011. Available at: http://www23.statcan.gc.ca:81/imdb/p2SV.pl Function=getSurvey&SDDS=5160&lang=en&db=imdb&adm=8&dis=2.

21. Rust KF, Rao JN. Variance estimation for complex surveys using replication techniques. Statistical Methods in Medical Research 1996; 5(3): 283-310.

22. Cameron C, Virani A, Dean H, et al. Utilization and expenditure on blood glucose test strips in Canada. Canadian Journal of Diabetes 2010; 34(1): 34-40.

23. Canadian Diabetes Association. The Prevalence and Costs of Diabetes.Toronto: Canadian Diabetes Association, 2009. Available at: www.diabetes.ca/files/PrevalenceandCost.pdf.

24. Johnson JA, Majumdar SR, Bowker SL, et al. Self-monitoring in type 2 diabetes: a randomized trial of reimbursement policy. Diabetic Medicine: A Journal of the British Diabetic Association 2006; 23(11): 1247-51.

25. Nyomba BL, Berard L, Murphy LJ. The cost of self-monitoring of blood glucose is an important factor limiting glycemic control in diabetic patients. Diabetes Care 2002; 25(7): 1244-5.

26. Mitchell CG, Simpson SH, Johnson JA. Observed costs of diabetes testing supplies in Saskatchewan. Canadian Journal of Clinical Pharmacology 2002; 9: 3.

27. Rosenbek Minet LK, Lonvig EM, Henriksen JE, Wagner L. The experience of living with diabetes following a self-management program based on motivational interviewing. Qualitative Health Research 2011; 21(8): 1115-26.

28. American Diabetes Association. Standards of medical care in diabetes - 2008. Diabetes Care 2011; 34: S1-S2.

29. Canadian Diabetes Association. 2008 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada. Canadian Journal of Diabetes 2008; 32(Suppl 1): S1-S201.

30. Sanyal C, Graham SD, Cooke C, et al. The relationship between type of drug therapy and blood glucose self-monitoring test strips claimed by beneficiaries of the Seniors’ Pharmacare Program in Nova Scotia, Canada. BMC Health Services Research 2008; 8: 111.

31. Belsey JD, Pittard JB, Rao S, et al. Self blood glucose monitoring in type 2 diabetes. A financial impact analysis based on UK primary care. International Journal of Clinical Practice 2009; 63(3): 439-48.

32. Karter AJ, Ferrara A, Darbinian JA, et al. Self-monitoring of blood glucose: language and financial barriers in a managed care population with diabetes. Diabetes Care 2000; 23(4): 477-83.